DataMEDS AI Co-Chief Executive Officer Gerald Commissiong bought 5,000 shares of the company’s common stock on Nov. 20, an open-market purchase rather than a financing transaction by the company.
- Commissiong paid $1.09 per share, for a total purchase price of $5,450.
- The shares trade on the Nasdaq Capital Market under the ticker MEDS.
- The purchase does not provide capital to DataMEDS; it was made by Commissiong in the market. The announcement did not state his total shareholdings after the purchase.
